Christopher C. Rowe
Researcher Next ID · RN-027820
Researcher · Medicine
Florey Institute of Neuroscience and Mental Health
Melbourne, Australia
- Works count
- 943
- Citation count
- 65,844
- H-index
- 101
- i10-index
- 322
Research interests
Publications
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
JAMA Neurology · 2024 · 10.1001/jamaneurol.2024.3770
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Nature Medicine · 2022 · 10.1038/s41591-022-02049-x
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00066-1
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
Nature · 2018 · https://doi.org/10.1038/nature25456
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Alzheimer s & Dementia · 2018 · https://doi.org/10.1016/j.jalz.2018.02.018
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
Nature Reviews Neurology · 2018 · 10.1038/nrneurol.2018.9
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Alzheimer s & Dementia · 2016 · https://doi.org/10.1016/j.jalz.2016.02.002
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Alzheimer s & Dementia · 2015 · 10.1016/j.jalz.2015.02.004
Alzheimer's disease
Nature Reviews Disease Primers · 2015 · 10.1038/nrdp.2015.56
Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA · 2015 · https://doi.org/10.1001/jama.2015.4669
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
Alzheimer s & Dementia · 2014 · 10.1016/j.jalz.2014.07.003
Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment
Molecular Psychiatry · 2014 · 10.1038/mp.2014.127
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
The Lancet Neurology · 2014 · https://doi.org/10.1016/s1474-4422(14)70090-0
Tau imaging: early progress and future directions
The Lancet Neurology · 2014 · 10.1016/s1474-4422(14)70252-2
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Alzheimer s & Dementia · 2013 · 10.1016/j.jalz.2013.01.002
Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
Diabetes Care · 2013 · 10.2337/dc13-0229
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(13)70044-9
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease
Proceedings of the National Academy of Sciences · 2013 · 10.1073/pnas.1317918110
Amyloid Imaging with18F-Florbetaben in Alzheimer Disease and Other Dementias
Journal of Nuclear Medicine · 2011 · 10.2967/jnumed.111.089730
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Alzheimer s & Dementia · 2011 · https://doi.org/10.1016/j.jalz.2011.03.003
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Annals of Neurology · 2011 · 10.1002/ana.22248
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Neurobiology of Aging · 2010 · 10.1016/j.neurobiolaging.2010.04.007
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
Journal of Neurology Neurosurgery & Psychiatry · 2008 · 10.1136/jnnp.2007.127878
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
The Lancet Neurology · 2008 · 10.1016/s1474-4422(08)70001-2
Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation
European Respiratory Journal · 1994 · 10.1183/09031936.94.07112016
Current projects
No projects listed.